Bloodstream infections in patients with liver cirrhosis

References

• Leon DA, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data. Lancet 2006; 367:52-6; PMID:16399153; http://dx.doi.org/10.1016/S0140-6736(06)67924-5
   PubMed Web of Science ®Google Scholar
• Fernandez J, Gustot T. Management of bacterial infections in cirrhosis. J Hepatol 2012; 56 Suppl 1:S1-12; PMID:22300459; http://dx.doi.org/10.1016/S0168-8278(12)60002-6
   PubMedGoogle Scholar
• Fernandez J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, Pavesi M, Sola E, Moreira L, Silva A, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology 2012; 55:1551-61; PMID:22183941; http://dx.doi.org/10.1002/hep.25532
   PubMed Web of Science ®Google Scholar
• Pant C, Olyaee M, Gilroy R, Pandya PK, Olson JC, Oropeza-Vail M, Rai T, Deshpande A. Emergency department visits related to cirrhosis: a retrospective study of the nationwide emergency department sample 2006 to 2011. Medicine 2015; 94:e308; PMID:25569646; http://dx.doi.org/10.1097/MD.0000000000000308
   PubMed Web of Science ®Google Scholar
• Merli M, Lucidi C, Giannelli V, Giusto M, Riggio O, Falcone M, Ridola L, Attili AF, Venditti M. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol 2010; 8:979-85; PMID:20621200; http://dx.doi.org/10.1016/j.cgh.2010.06.024
   PubMed Web of Science ®Google Scholar
• De Rosa FG, Corcione S, Filippini C, Raviolo S, Fossati L, Montrucchio C, Aldieri C, Petrolo A, Cavallo R, Di Perri G. The Effect on mortality of fluconazole or echinocandins treatment in candidemia in internal medicine wards [corrected]. PloS One 2015; 10:e0125149; PMID:25938486; http://dx.doi.org/10.1371/journal.pone.0125149
   PubMed Web of Science ®Google Scholar
• Arvaniti V, D'Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, Burroughs AK. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterol 2010; 139:1246-56, 56 e1-5
   PubMed Web of Science ®Google Scholar
• Leber B, Spindelboeck W, Stadlbauer V. Infectious complications of acute and chronic liver disease. Seminars Resp Critical Care Med 2012; 33:80-95; PMID:22447263; http://dx.doi.org/10.1055/s-0032-1301737
   PubMed Web of Science ®Google Scholar
• Thulstrup AM, Sorensen HT, Schonheyder HC, Moller JK, Tage-Jensen U. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis 2000; 31:1357-61; PMID:11096002; http://dx.doi.org/10.1086/317494
   PubMed Web of Science ®Google Scholar
• Bellot P, Frances R, Such J. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications. Liver Int 2013; 33:31-9; PMID:23121656; http://dx.doi.org/10.1111/liv.12021
   PubMed Web of Science ®Google Scholar
• Albillos A, Lario M, Alvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol 2014; 61:1385-96; PMID:25135860; http://dx.doi.org/10.1016/j.jhep.2014.08.010
   PubMed Web of Science ®Google Scholar
• Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35:140-8; PMID:11786970; http://dx.doi.org/10.1053/jhep.2002.30082
   PubMed Web of Science ®Google Scholar
• Sargenti K, Prytz H, Strand A, Nilsson E, Kalaitzakis E. Healthcare-associated and nosocomial bacterial infections in cirrhosis: predictors and impact on outcome. Liver Int 2015; 35:391-400; PMID:25039438; http://dx.doi.org/10.1111/liv.12625
   PubMed Web of Science ®Google Scholar
• Aggarwal A, Ong JP, Younossi ZM, Nelson DR, Hoffman-Hogg L, Arroliga AC. Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU. Chest 2001; 119:1489-97; PMID:11348958; http://dx.doi.org/10.1378/chest.119.5.1489
   PubMed Web of Science ®Google Scholar
• Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, Stadlbauer V, Gustot T, Bernardi M, Canton R, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol 2014; 60:1310-24; PMID:24530646; http://dx.doi.org/10.1016/j.jhep.2014.01.024
   PubMed Web of Science ®Google Scholar
• Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM. Predictive scoring model of mortality in Gram-negative bloodstream infection. Clin Microbiol Infect 2013; 19:948-54; PMID:23190091; http://dx.doi.org/10.1111/1469-0691.12085
   PubMed Web of Science ®Google Scholar
• De Rosa FG, Corcione S, Raviolo S, Montrucchio C, Aldieri C, Pagani N, Di Perri G. Candidemia, and infections by Clostridium difficile and carbapenemase-producing Enterobacteriaceae: new enteropathogenetic opportunistic syndromes?. Le infezioni Med 2015; 23:105-16; PMID:26110290
   PubMedGoogle Scholar
• Kang CI, Song JH, Chung DR, Peck KR, Yeom JS, Ki HK, Son JS, Lee JS, Kim YS, Jung SI, et al. Liver cirrhosis as a risk factor for mortality in a national cohort of patients with bacteremia. J Infect 2011; 63:336-43; PMID:21835195; http://dx.doi.org/10.1016/j.jinf.2011.07.012
   PubMed Web of Science ®Google Scholar
• Hirakata Y, Tomono K, Tateda K, Matsumoto T, Furuya N, Shimoguchi K, Kaku M, Yamaguchi K. Role of bacterial association with Kupffer cells in occurrence of endogenous systemic bacteremia. Infect Immun 1991; 59:289-94; PMID:1987043
   PubMed Web of Science ®Google Scholar
• Katz S, Jimenez MA, Lehmkuhler WE, Grosfeld JL. Liver bacterial clearance following hepatic artery ligation and portacaval shunt. J Surg Res 1991; 51:267-70; PMID:1881140; http://dx.doi.org/10.1016/0022-4804(91)90105-U
   PubMed Web of Science ®Google Scholar
• Bonnel AR, Bunchorntavakul C, Reddy KR. Immune dysfunction and infections in patients with cirrhosis. Clin Gastroenterol hepatol 2011; 9:727-38; PMID:21397731; http://dx.doi.org/10.1016/j.cgh.2011.02.031
   PubMed Web of Science ®Google Scholar
• Broering R, Lu M, Schlaak JF. Role of Toll-like receptors in liver health and disease. Clin Sci (Lond) 2011; 121:415-26; PMID:21797822; http://dx.doi.org/10.1042/CS20110065
   PubMed Web of Science ®Google Scholar
• Sipeki N, Antal-Szalmas P, Lakatos PL, Papp M. Immune dysfunction in cirrhosis. World J Gastroenterol 2014; 20:2564-77; http://dx.doi.org/10.3748/wjg.v20.i10.2564
   PubMed Web of Science ®Google Scholar
• Fiuza C, Salcedo M, Clemente G, Tellado JM. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 2000; 182:526-33; PMID:10915084; http://dx.doi.org/10.1086/315742
   PubMed Web of Science ®Google Scholar
• Gomez F, Ruiz P, Schreiber AD. Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. N Eng J Med 1994; 331:1122-8; PMID:7935636; http://dx.doi.org/10.1056/NEJM199410273311704
   PubMed Web of Science ®Google Scholar
• Tritto G, Bechlis Z, Stadlbauer V, Davies N, Frances R, Shah N, Mookerjee RP, Such J, Jalan R. Evidence of neutrophil functional defect despite inflammation in stable cirrhosis. J Hepatol 2011; 55:574-81; PMID:21236309; http://dx.doi.org/10.1016/j.jhep.2010.11.034
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Hylemon PB, Ridlon JM, Heuman DM, Daita K, White MB, Monteith P, Noble NA, Sikaroodi M, Gillevet PM. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointestinal Liver Physiol 2012; 303:G675-85; PMID:22821944; http://dx.doi.org/10.1152/ajpgi.00152.2012
   PubMed Web of Science ®Google Scholar
• Weingarden AR, Chen C, Bobr A, Yao D, Lu Y, Nelson VM, Sadowsky MJ, Khoruts A. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointestinal Liver Physiol 2014; 306:G310-9; PMID:24284963; http://dx.doi.org/10.1152/ajpgi.00282.2013
   PubMed Web of Science ®Google Scholar
• Song Y, Garg S, Girotra M, Maddox C, von Rosenvinge EC, Dutta A, Dutta S, Fricke WF. Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PloS One 2013; 8:e81330; PMID:24303043; http://dx.doi.org/10.1371/journal.pone.0081330
   PubMed Web of Science ®Google Scholar
• Perez-Paramo M, Munoz J, Albillos A, Freile I, Portero F, Santos M, Ortiz-Berrocal J. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 2000; 31:43-8; PMID:10613726; http://dx.doi.org/10.1002/hep.510310109
   PubMed Web of Science ®Google Scholar
• Gunnarsdottir SA, Sadik R, Shev S, Simren M, Sjovall H, Stotzer PO, Abrahamsson H, Olsson R, Bjornsson ES. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol 2003; 98:1362-70; PMID:12818282; http://dx.doi.org/10.1111/j.1572-0241.2003.07475.x
   PubMed Web of Science ®Google Scholar
• Bajaj JS, Heuman DM, Hylemon PB, Sanyal AJ, White MB, Monteith P, Noble NA, Unser AB, Daita K, Fisher AR, et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol 2014; 60:940-7; PMID:24374295; http://dx.doi.org/10.1016/j.jhep.2013.12.019
   PubMed Web of Science ®Google Scholar
• Merli M, Lucidi C, Di Gregorio V, Giannelli V, Giusto M, Ceccarelli G, Riggio O, Venditti M. The chronic use of β-blockers and proton pump inhibitors may affect the rate of bacterial infections in cirrhosis. Liver Int 2015; 35:362-9; PMID:24836902; http://dx.doi.org/10.1111/liv.12593
   PubMed Web of Science ®Google Scholar
• Cirera I, Bauer TM, Navasa M, Vila J, Grande L, Taura P, Fuster J, Garcia-Valdecasas JC, Lacy A, Suarez MJ, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001; 34:32-7; PMID:11211904; http://dx.doi.org/10.1016/S0168-8278(00)00013-1
   PubMed Web of Science ®Google Scholar
• Scarpellini E, Valenza V, Gabrielli M, Lauritano EC, Perotti G, Merra G, Dal Lago A, Ojetti V, Ainora ME, Santoro M, et al. Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? Am J Gastroenterol 2010; 105:323-7; PMID:19844200; http://dx.doi.org/10.1038/ajg.2009.558
   PubMed Web of Science ®Google Scholar
• Campillo B, Pernet P, Bories PN, Richardet JP, Devanlay M, Aussel C. Intestinal permeability in liver cirrhosis: relationship with severe septic complications. Eur J Gastroenterol Hepatol 1999; 11:755-9; PMID:10445796; http://dx.doi.org/10.1097/00042737-199907000-00013
   PubMed Web of Science ®Google Scholar
• Campillo B, Richardet JP, Kheo T, Dupeyron C. Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis 2002; 35:1-10; PMID:12060868; http://dx.doi.org/10.1086/340617
   PubMed Web of Science ®Google Scholar
• Bartoletti M, Giannella M, Caraceni P, Domenicali M, Ambretti S, Tedeschi S, Verucchi G, Badia L, Lewis RE, Bernardi M, et al. Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. J Hepatol 2014; 61:51-8; PMID:24681345; http://dx.doi.org/10.1016/j.jhep.2014.03.021
   PubMed Web of Science ®Google Scholar
• Hsieh CC, Lee CC, Chan TY, Hong MY, Chi CH, Ko WC. Clinical features and impact of empirical therapy in cirrhotic adults with community-onset bacteremia. Am J Emergency Med 2015; 33:222-8; PMID:25498529; http://dx.doi.org/10.1016/j.ajem.2014.11.024
   PubMed Web of Science ®Google Scholar
• Park H, Jang KJ, Jang W, Park SH, Park JY, Jeon TJ, Oh TH, Shin WC, Choi WC, Sinn DH. Appropriate empirical antibiotic use and 30-d mortality in cirrhotic patients with bacteremia. World J Gastroenterol 2015; 21:3587-92; http://dx.doi.org/10.3748/wjg.v21.i12.3587
   PubMed Web of Science ®Google Scholar
• Brandolini M, Corbella M, De Silvestri A, Tinelli C, Albonico G, Albertini R, Ludovisi S, Bruno R, Marone P, Minoli L, et al. Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease. Infection 2015; 43(5):561-7; PMID:25976737
   PubMed Web of Science ®Google Scholar
• Merli M, Lucidi C, Di Gregorio V, Falcone M, Giannelli V, Lattanzi B, Giusto M, Ceccarelli G, Farcomeni A, Riggio O, et al. The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey. PloS One 2015; 10(5):e0127448; PMID:25996499; http://dx.doi.org/10.1371/journal.pone.0127448
   PubMed Web of Science ®Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268-81; PMID:21793988; http://dx.doi.org/10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Novovic S, Semb S, Olsen H, Moser C, Knudsen JD, Homann C. First-line treatment with cephalosporins in spontaneous bacterial peritonitis provides poor antibiotic coverage. Scandinavian J Gastroenterol 2012; 47:212-6; PMID:22191479; http://dx.doi.org/10.3109/00365521.2011.645502
   PubMed Web of Science ®Google Scholar
• Choi SH, Park HG, Jun JB, Lee SO, Woo JH, Kim YS. Clinical characteristics and outcomes of pneumococcal bacteremia in adult patients with liver cirrhosis. Diagnostic Microbiol Infect Dis 2009; 63:160-4; PMID:19150708; http://dx.doi.org/10.1016/j.diagmicrobio.2008.10.018
   PubMed Web of Science ®Google Scholar
• Cho SY, Kang CI, Kim J, Joo EJ, Ha YE, Chung DR, Lee NY, Peck KR, Song JH. Association of liver cirrhosis with group B streptococcal bacteremia in non-pregnant adults. J Infect 2013; 67:617-9; PMID:23999150; http://dx.doi.org/10.1016/j.jinf.2013.08.015
   PubMed Web of Science ®Google Scholar
• Bartoletti M, Giannella M, Lewis RE, Viale P. Epidemiology of Bloodstream Infection in Cirrhostic Patients: A Prospective Multicenter Study (BICHROME). Poster K-811. 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). San Diego, CA, 2015
   Google Scholar
• Kaukonen KM, Bailey M, Pilcher D, Cooper DJ, Bellomo R. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Eng J Med 2015; 372:1629-38; PMID:25776936; http://dx.doi.org/10.1056/NEJMoa1415236
   PubMed Web of Science ®Google Scholar
• Wong F, Bernardi M, Balk R, Christman B, Moreau R, Garcia-Tsao G, Patch D, Soriano G, Hoefs J, Navasa M. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 2005; 54:718-25; PMID:15831923; http://dx.doi.org/10.1136/gut.2004.038679
   PubMed Web of Science ®Google Scholar
• Mackenzie I, Woodhouse J. C-reactive protein concentrations during bacteraemia: A comparison between patients with and without liver dysfunction. Intensive Care Med 2006; 32:1344-51; PMID:16799774; http://dx.doi.org/10.1007/s00134-006-0251-1
   PubMed Web of Science ®Google Scholar
• Papp M, Vitalis Z, Altorjay I, Tornai I, Udvardy M, Harsfalvi J, Vida A, Kappelmayer J, Lakatos PL, Antal-Szalmas P. Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections. Liver Int 2012; 32:603-11; PMID:22145664; http://dx.doi.org/10.1111/j.1478-3231.2011.02689.x
   PubMed Web of Science ®Google Scholar
• Karvellas CJ, Pink F, McPhail M, Austin M, Auzinger G, Bernal W, Sizer E, Kutsogiannis DJ, Eltringham I, Wendon JA. Bacteremia, acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure. Critical Care Med 2010; 38:121-6; PMID:19770744; http://dx.doi.org/10.1097/CCM.0b013e3181b42a1c
   PubMed Web of Science ®Google Scholar
• Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial Infections. Ann Internal Med 2004; 140:26-32; PMID:14706969; http://dx.doi.org/10.7326/0003-4819-140-1-200401060-00008
   PubMed Web of Science ®Google Scholar
• Thabut D, Massard J, Gangloff A, Carbonell N, Francoz C, Nguyen-Khac E, Duhamel C, Lebrec D, Poynard T, Moreau R. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology 2007; 46:1872-82; PMID:17972337; http://dx.doi.org/10.1002/hep.21920
   PubMed Web of Science ®Google Scholar
• Viasus D, Garcia-Vidal C, Castellote J, Adamuz J, Verdaguer R, Dorca J, Manresa F, Gudiol F, Carratala J. Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores. Medicine 2011; 90:110-8; PMID:21358441; http://dx.doi.org/10.1097/MD.0b013e318210504c
   PubMed Web of Science ®Google Scholar
• Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterol 2013; 144:1426-37, 37 e1-9
   PubMed Web of Science ®Google Scholar
• Hung TH, Hsieh YH, Tseng KC, Tsai CC. The risk for bacterial endocarditis in cirrhotic patients: a population-based 3-year follow-up study. Int J Infect Dis 2013; 17:e391-3; PMID:23352807; http://dx.doi.org/10.1016/j.ijid.2012.12.009
   PubMed Web of Science ®Google Scholar
• Hsu RB, Chen RJ, Chu SH. Infective endocarditis in patients with liver cirrhosis. J Formosan Med Association = Taiwan yi zhi 2004; 103:355-8; PMID:15216401
   PubMed Web of Science ®Google Scholar
• Park SY, Park KH, Bang KM, Chong YP, Kim SH, Lee SO, Choi SH, Jeong JY, Woo JH, Kim YS. Clinical significance and outcome of polymicrobial Staphylococcus aureus bacteremia. J Infect 2012; 65:119-27; PMID:22410381; http://dx.doi.org/10.1016/j.jinf.2012.02.015
   PubMed Web of Science ®Google Scholar
• Fernandez Guerrero ML, Gonzalez Lopez J, Gorgolas M. Infectious endocarditis in patients with cirrhosis of the liver: a model of infection in the frail patient. Eur J Clin Microbiol Infect Dis 2010; 29:1271-5; http://dx.doi.org/10.1007/s10096-010-0998-8
   PubMed Web of Science ®Google Scholar
• McCashland TM, Sorrell MF, Zetterman RK. Bacterial endocarditis in patients with chronic liver disease. Am J Gastroenterol 1994; 89:924-7; PMID:8198106
   PubMed Web of Science ®Google Scholar
• Sanyal AJ, Reddy KR. Vegetative infection of transjugular intrahepatic portosystemic shunts. Gastroenterol 1998; 115:110-5; PMID:9649465; http://dx.doi.org/10.1016/S0016-5085(98)70371-3
   PubMed Web of Science ®Google Scholar
• Mizrahi M, Adar T, Shouval D, Bloom AI, Shibolet O. Endotipsitis-persistent infection of transjugular intrahepatic portosystemic shunt: pathogenesis, clinical features and management. Liver Int 2010; 30:175-83; PMID:19929905; http://dx.doi.org/10.1111/j.1478-3231.2009.02158.x
   PubMed Web of Science ®Google Scholar
• DeSimone JA, Beavis KG, Eschelman DJ, Henning KJ. Sustained bacteremia associated with transjugular intrahepatic portosystemic shunt (TIPS). Clin Infect Dis 2000; 30:384-6; PMID:10671346; http://dx.doi.org/10.1086/313653
   PubMed Web of Science ®Google Scholar
• Armstrong PK, MacLeod C. Infection of transjugular intrahepatic portosystemic shunt devices: three cases and a review of the literature. Clin Infect Dis 2003; 36:407-12; PMID:12567297; http://dx.doi.org/10.1086/346156
   PubMed Web of Science ®Google Scholar
• Navaratnam AM, Grant M, Banach DB. Endotipsitis: A case report with a literature review on an emerging prosthetic related infection. World J Hepatol 2015; 7:710-6; PMID:25866608; http://dx.doi.org/10.4254/wjh.v7.i4.710
   PubMedGoogle Scholar
• Pea F, Viale P. Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock–does the dose matter? Crit Care 2009; 13:214; PMID:19519961; http://dx.doi.org/10.1186/cc7774
   PubMed Web of Science ®Google Scholar
• Westphal JF, Jehl F, Vetter D. Pharmacological, toxicologic, and microbiological considerations in the choice of initial antibiotic therapy for serious infections in patients with cirrhosis of the liver. Clin Infect Dis 1994; 18:324-35; PMID:7741830; http://dx.doi.org/10.1093/clinids/18.3.324
   PubMed Web of Science ®Google Scholar
• Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Critical Care Med 2009; 37:840-51; quiz 59; PMID:19237886; http://dx.doi.org/10.1097/CCM.0b013e3181961bff
   PubMed Web of Science ®Google Scholar
• Blot SI, Pea F, Lipman J. The effect of pathophysiology on pharmacokinetics in the critically ill patient-concepts appraised by the example of antimicrobial agents. Adv Drug Delivery Rev 2014; 77:3-11; PMID:25038549; http://dx.doi.org/10.1016/j.addr.2014.07.006
   PubMed Web of Science ®Google Scholar
• Henriksen JH, Kiszka-Kanowitz M, Bendtsen F. Review article: volume expansion in patients with cirrhosis. Alimentary Pharmacol Therapeutics 2002; 16(Suppl 5):12-23; PMID:12423449; http://dx.doi.org/10.1046/j.1365-2036.16.s5.3.x
   PubMed Web of Science ®Google Scholar
• Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol 2008; 64:1147-61; PMID:18762933; http://dx.doi.org/10.1007/s00228-008-0553-z
   PubMed Web of Science ®Google Scholar
• Gines P, Schrier RW. Renal failure in cirrhosis. N Eng J Med 2009; 361:1279-90; PMID:19776409; http://dx.doi.org/10.1056/NEJMra0809139
   PubMed Web of Science ®Google Scholar
• Proulx NL, Akbari A, Garg AX, Rostom A, Jaffey J, Clark HD. Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis. Nephrol Dialysis Transplantation 2005; 20:1617-22; PMID:15855207; http://dx.doi.org/10.1093/ndt/gfh839
   PubMed Web of Science ®Google Scholar